Solventum

Health Care Health Care Technology Saint Paul, Minnesota Last filing Feb 27, 2026 · FY2025

                    Revenue
                    FY2025
                
$8.3B
                    3y CAGR +0.8%
                    
                    P20
                    
                    n/a
                    
                    Net income
                    FY2025
                
$1.6B
                    Net margin +18.7%
                    
                    P75
                    
                    n/a
                    
                    Total assets
                    FY2025
                
$14.3B
                    ROA +10.9%
                    
                    P73
                    
                    n/a
                    
                    Operating cash flow
                    FY2025
                
$369.0M
                    FCF margin -0.1%
                    
                    P6
                    
                    n/a

4 yrs · FY2022–FY2025 9 filed · 0 derived · 0 blank

1Y 3Y 5Y

Dollars % of revenue % of assets YoY % CAGR

Each cell as a share of that year’s revenue.

Balance Sheet

Assets, liabilities, and equity

28 accounts · 1 year

Total assets $14.3B

Total liabilities $9.2B

Shareholders equity $5.0B

Account	2025	Trend
Assets
Cash and Cash Equivalents	10.5%
Accounts Receivable	12.4%
Inventory	12.8%
Prepaid Expenses	8.8%
Other Current Assets	8.8%
Total Current Assets	46.4%
Property,Plant and Equipment	0.0%
Operating Lease Assets	2.6%
Goodwill	68.5%
Intangible Assets	31.1%
Other Noncurrent Assets	9.8%
Total Assets	171.7%
Liabilities
Accounts Payable	8.3%
Accrued Liabilities	5.2%
Deferred Revenue	7.5%
Current Portion of Long Term Debt	0.0%
Other Current Liabilities	16.7%
Total Current Liabilities	37.7%
Long Term Debt	60.5%
Deferred Tax Liabilities	2.0%
Other Noncurrent Liabilities	6.6%
Total Liabilities	111.1%
Equity
Common Stock	0.0%
Additional Paid In Capital	46.6%
Retained Earnings	21.6%
Accumulated Other Comprehensive Income	-7.5%
Total Stockholders Equity	60.6%
Total Liabilitiesand Equity	171.7%

Income Statement

Revenue, expense, and profitability

16 accounts · 1 year

Revenue $8.3B

Operating income $2.2B

Net income $1.6B

Account	2025	Trend
IncomeStatement
Revenues Total Revenue	100.0%
Expenses Research and Development	8.9%
Expenses Selling,General and Administrative	37.0%
Expenses Depreciation and Amortization	5.9%
Expenses Share Based Compensation	1.9%
Other Income Expense Gross Profit	53.5%
Other Income Expense Operating Income	26.2%
Other Income Expense Other Income/expense	-0.5%
Other Income Expense Income Before Tax	20.6%
Income Tax Income Tax Expense	1.9%
net Income net Income	18.7%
net Income Comprehensive Income	23.9%
Earnings Per Share Basic Eps	0.0%
Earnings Per Share Diluted Eps	0.0%
Earnings Per Share Weighted Average Shares Basic	2.1%
Earnings Per Share Weighted Average Shares Diluted	2.1%

Cash Flow Statement

Operating, investing, and financing flows

20 accounts · 1 year

Operating cash flow $369.0M

Investing cash flow $2.8B

Financing cash flow $-3.1B

Account	2025	Trend
CashFlow
Operating Activities net Income	18.7%
Operating Activities Depreciation and Amortization	5.9%
Operating Activities Stock Based Compensation	1.9%
Operating Activities Deferred Income Taxes	-1.4%
Operating Activities Changes In Operating Assets and Liabilities	2.5%
Operating Activities Other Non Cash Items	-2.3%
Operating Activities net Cash From Operating Activities	4.4%
Investing Activities Capital Expenditures	4.6%
Investing Activities Business Acquisitions	8.4%
Investing Activities Other Investing Activities	0.2%
Investing Activities net Cash From Investing Activities	33.6%
Financing Activities Proceeds From Debt	0.0%
Financing Activities Repayment of Debt	36.9%
Financing Activities Tax Withholding On Stock Based Compensation	0.3%
Financing Activities Other Financing Activities	0.6%
Financing Activities net Cash From Financing Activities	-36.7%
Cash Reconciliation Effect of Exchange Rate On Cash	10.5%
Cash Reconciliation net Change In Cash	1.4%
Cash Reconciliation Cash At Beginning of Period	10.5%
Cash Reconciliation Cash At End of Period	10.5%

Key Ratios

Margins, returns, liquidity, leverage, efficiency

Computed at import · 1 year

Ratio	2025
Profitability
Gross margin	—
Operating margin	+26.2%
Net margin	+18.7%
FCF margin	-0.1%
Growth
Revenue CAGR (3y)	+0.8%
Returns
ROE	+30.8%
ROA	+10.9%
ROIC	+21.5%
Liquidity
Current ratio	1.23x
Quick ratio	0.61x
Leverage
D/E	1.83x
Interest coverage	—
Efficiency
Asset turnover	0.58x
Cash conversion cycle	—

Valuation

Price against fundamentals

FY2025 fundamentals · no price

No price data cached, so there is nothing to multiply. Load prices from the Stock Data tab and this panel reprices itself.

Notes

Your annotations

Not watched

Solventum

Assets, liabilities, and equity

Revenue, expense, and profitability

Operating, investing, and financing flows

Margins, returns, liquidity, leverage, efficiency

Price against fundamentals

Your annotations

One-year price and volume history

Price data unavailable

Assets, liabilities, and equity

Revenue, expense, and profitability

Operating, investing, and financing flows

Margins, returns, liquidity, leverage, efficiency

Price against fundamentals

Your annotations

One-year price and volume history

Price data unavailable

Recent price history